(Q33890560)

29 July 2017

1 reference

title

Recent advances in cancer chemoprevention, with emphasis on breast and colorectal cancer (English)

1 reference

29 July 2017

1 reference

1 reference

Decensi A

1

1 reference

PubMed ID

10762741

29 July 2017

Costa A

series ordinal

2

1 reference

29 July 2017

1 April 2000

1 reference

European Journal of Cancer

29 July 2017

1 reference

29 July 2017

36

1 reference

29 July 2017

6

1 reference

29 July 2017

694-709

1 reference

Cancer chemoprevention: progress and promise

29 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900040-X

7 January 2021

Projecting individualized probabilities of developing breast cancer for white females who are being examined annually

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900040-X

7 January 2021

Epidemiology of colorectal adenomas

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900040-X

7 January 2021

Identification of FAP locus genes from chromosome 5q21

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900040-X

7 January 2021

Inheritance of Cancer of the Stomach and Large Intestine in Man2

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900040-X

7 January 2021

The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900040-X

7 January 2021

Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900040-X

7 January 2021

Can fenretinide protect women against ovarian cancer?

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900040-X

7 January 2021

Circulating concentrations of insulin-like growth factor I and risk of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900040-X

7 January 2021

Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900040-X

7 January 2021

Plasma levels of insulin-like growth factor-I and lung cancer risk: a case-control analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900040-X

7 January 2021

Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900040-X

7 January 2021

Insulin-like growth factor-I: a key regulator of human cancer risk?

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900040-X

7 January 2021

Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900040-X

7 January 2021

Effect of fenretinide on plasma IGF-I and IGFBP-3 in early breast cancer patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900040-X

7 January 2021

Effect of tamoxifen on serum insulinlike growth factor I levels in stage I breast cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900040-X

7 January 2021

Quantitative classification of mammographic densities and breast cancer risk: results from the Canadian National Breast Screening Study

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900040-X

7 January 2021

Mammographic features and breast cancer risk: effects with time, age, and menopause status.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900040-X

7 January 2021

A nested case-control study of mammographic patterns, breast volume, and breast cancer (New York City, NY, United States).

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900040-X

7 January 2021

Can mammographic densities predict effects of tamoxifen on the breast?

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900040-X

7 January 2021

Effects at two years of a low-fat, high-carbohydrate diet on radiologic features of the breast: results from a randomized trial. Canadian Diet and Breast Cancer Prevention Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900040-X

7 January 2021

Mammographic densities as a criterion for entry to a clinical trial of breast cancer prevention

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900040-X

7 January 2021

Interim analysis of the incidence of breast cancer in the Royal Marsden Hospital tamoxifen randomised chemoprevention trial

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900040-X

7 January 2021

Prevention of breast cancer with tamoxifen: preliminary findings from the Italian randomised trial among hysterectomised women. Italian Tamoxifen Prevention Study

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900040-X

7 January 2021

Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900040-X

7 January 2021

Drop-outs in tamoxifen prevention trials

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900040-X

7 January 2021

Effect of tamoxifen and transdermal hormone replacement therapy on cardiovascular risk factors in a prevention trial. Italian Chemoprevention Group

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900040-X

7 January 2021

Alteration of endocrine parameters in premenopausal women with breast cancer during long-term adjuvant therapy with tamoxifen as the single agent

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900040-X

7 January 2021

Long-term tamoxifen citrate use and potential ocular toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900040-X

7 January 2021

Effects of raloxifene on bone mineral density, serum cholesterol concentrations, and uterine endometrium in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900040-X

7 January 2021

A new class of retinoids with selective inhibition of AP-1 inhibits proliferation

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900040-X

7 January 2021

Modulation of the insulin-like growth factor-I system by N-(4-hydroxyphenyl)-retinamide in human breast cancer cell lines.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900040-X

7 January 2021

Retinoids and apoptosis: implications for cancer chemoprevention and therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900040-X

7 January 2021

Randomized trial of fenretinide to prevent second breast malignancy in women with early breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900040-X

7 January 2021

Combination chemoprevention of cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900040-X

7 January 2021

Phase I/II trial of tamoxifen with or without fenretinide, an analog of vitamin A, in women with metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900040-X

7 January 2021

Pilot trial of the safety, tolerability, and retinoid levels of N-(4-hydroxyphenyl) retinamide in combination with tamoxifen in patients at high risk for developing invasive breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900040-X

7 January 2021

Colorectal cancer and nonsteroidal anti-inflammatory drugs.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900040-X

7 January 2021

Sulindac for polyposis of the colon.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900040-X

7 January 2021

Cyclooxygenase-2 inhibitors in tumorigenesis (part I)

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900040-X

7 January 2021

Cyclooxygenase-2 inhibitors in tumorigenesis (Part II)

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900040-X

7 January 2021

Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900040-X

7 January 2021

Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2)

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900040-X

7 January 2021

Review article: COX-II inhibitors--a new generation of safer NSAIDs?

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900040-X

7 January 2021

Epidemiology and risk factors for colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900040-X

7 January 2021

Calcium supplements for the prevention of colorectal adenomas. Calcium Polyp Prevention Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900040-X

7 January 2021

The enzyme-activated irreversible inhibitor of ornithine decarboxylase, DL-alpha-difluoromethylornithine: a chemopreventive agent

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900040-X

7 January 2021

Development of difluoromethylornithine as a chemoprevention agent for the management of colon cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900040-X

7 January 2021

A clinical trial of antioxidant vitamins to prevent colorectal adenoma. Polyp Prevention Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900040-X

7 January 2021

Randomized trial of intake of fat, fiber, and beta carotene to prevent colorectal adenomas

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900040-X

7 January 2021

Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900040-X

7 January 2021

CHEMOPREVENTION OF LUNG CANCER: The Rise and Demise of Beta-Carotene

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900040-X

7 January 2021

Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900040-X

7 January 2021

Physicians' health study: aspirin and primary prevention of coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900040-X

7 January 2021

Beta-Carotene, vitamin A, and lung cancer chemoprevention: results of an intermediate endpoint study.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900040-X

7 January 2021

Adjuvant treatment of stage I lung cancer with high-dose vitamin A.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900040-X

7 January 2021

Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neck

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900040-X

7 January 2021

Prevention of second primary tumors with isotretinoin in patients with squamous cell carcinoma of the head and neck: long-term follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900040-X

7 January 2021

Randomized placebo-controlled trial of isotretinoin in chemoprevention of bronchial squamous metaplasia.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900040-X

7 January 2021

Long-term therapy with low-dose isotretinoin for prevention of basal cell carcinoma: a multicenter clinical trial. Isotretinoin-Basal Cell Carcinoma Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900040-X

7 January 2021

Prevention of skin cancer and reduction of keratotic skin lesions during acitretin therapy in renal transplant recipients: a double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900040-X

7 January 2021

Nutrition intervention trials in Linxian, China: supplementation with specific vitamin/mineral combinations, cancer incidence, and disease-specific mortality in the general population

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900040-X

7 January 2021

Prevention of second primary tumors by an acyclic retinoid, polyprenoic acid, in patients with hepatocellular carcinoma. Hepatoma Prevention Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900040-X

7 January 2021

Prevention of second primary tumors by an acyclic retinoid in patients with hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900040-X

7 January 2021

Enhancement of regression of cervical intraepithelial neoplasia II (moderate dysplasia) with topically applied all-trans-retinoic acid: a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900040-X

7 January 2021

Prostate Cancer and Supplementation With α-Tocopherol and β-Carotene: Incidence and Mortality in a Controlled Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900040-X

7 January 2021

Selenium, vitamin E, and prostate cancer--ready for prime time?

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900040-X

7 January 2021

Chemoprevention of prostate cancer: the Prostate Cancer Prevention Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900040-X

7 January 2021

10.1016/S0959-8049(00)00040-X

Identifiers

DOI

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/kapnow5tq5eqpj2zjnb7coixui

30 July 2022

mapped directly with Wikidata item

Fatcat ID

release_kapnow5tq5eqpj2zjnb7coixui

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/kapnow5tq5eqpj2zjnb7coixui

30 July 2022

mapped directly with Wikidata item

1 reference

https://api.fatcat.wiki/v0/release/kapnow5tq5eqpj2zjnb7coixui

30 July 2022